Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
Authors
Keywords
-
Journal
JOURNAL OF PHARMACY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-01-01
DOI
10.1093/jpp/rgaa063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of statins on Parkinsonʼs disease
- (2019) Junqiang Yan et al. MEDICINE
- Parkinson's Disease and Parkinsonism
- (2019) Michael T Hayes AMERICAN JOURNAL OF MEDICINE
- Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
- (2019) Irina Alecu et al. Frontiers in Neuroscience
- Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
- (2019) Uram Jin et al. Experimental Neurobiology
- 27-Hydroxycholesterol increases α-synuclein protein levels through proteasomal inhibition in human dopaminergic neurons
- (2018) Jared Schommer et al. BMC NEUROSCIENCE
- Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
- (2018) Amin Karimi-Moghadam et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein
- (2018) Tammy Ryan et al. Nature Communications
- A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition
- (2018) Talia Zeppelin et al. PLoS Computational Biology
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study
- (2018) Violetta Rozani et al. MOVEMENT DISORDERS
- Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice
- (2018) Rajib Paul et al. NEUROSCIENCE
- Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment
- (2018) Saranna Fanning et al. MOLECULAR CELL
- Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity
- (2018) Benjamin M. Vincent et al. Cell Reports
- The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
- (2017) Courtney Lane-Donovan et al. JOURNAL OF LIPID RESEARCH
- Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
- (2017) Fatemeh Nouri Emamzadeh JOURNAL OF MOLECULAR NEUROSCIENCE
- Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells
- (2017) Elena Chiricozzi et al. JOURNAL OF NEUROCHEMISTRY
- α-Synuclein Regulates Neuronal Cholesterol Efflux
- (2017) Jen-Hsiang Hsiao et al. MOLECULES
- Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
- (2017) Guodong Liu et al. MOVEMENT DISORDERS
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Statins and Cognition in Parkinson’s Disease
- (2017) Benjamin L. Deck et al. Journal of Parkinsons Disease
- Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress
- (2017) Camille B. Carroll et al. Journal of Parkinsons Disease
- Low LDL cholesterol,PCSK9andHMGCRgenetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
- (2017) Marianne Benn et al. BMJ-British Medical Journal
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson’s disease: Involvement of mitochondrial dysfunctions and oxidative stress
- (2017) Rajib Paul et al. PLoS One
- Cholesterol Biosynthesis: A Mechanistic Overview
- (2016) Nuno M. F. S. A. Cerqueira et al. BIOCHEMISTRY
- Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease
- (2016) Margaux Doria et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease
- (2016) Fatemeh Nouri Emamzadeh et al. NEUROSCIENCE LETTERS
- Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes
- (2015) Andreas van Maarschalkerweerd et al. FEBS LETTERS
- Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson’s Disease
- (2015) Kyle Farmer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients
- (2015) Christine R. Swanson et al. MOVEMENT DISORDERS
- Cholesterol – A putative endogenous contributor towards Parkinson's disease
- (2015) Rajib Paul et al. NEUROCHEMISTRY INTERNATIONAL
- Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies
- (2015) Keiko Nakamura et al. NEUROPATHOLOGY
- 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
- (2015) Min-Yu Sun et al. NEUROSCIENTIST
- Cholesterol metabolism and homeostasis in the brain
- (2015) Juan Zhang et al. Protein & Cell
- HDL and cholesterol handling in the brain
- (2014) C. Vitali et al. CARDIOVASCULAR RESEARCH
- Cholesterol in brain disease: sometimes determinant and frequently implicated
- (2014) M. G. Martin et al. EMBO REPORTS
- The serum lipid profile of Parkinson's disease patients: a study from China
- (2014) Xiaoyan Guo et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Acceleration of α-Synuclein Aggregation by Exosomes
- (2014) Marie Grey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma apolipoprotein A1 as a biomarker for Parkinson disease
- (2013) Judy K. Qiang et al. ANNALS OF NEUROLOGY
- Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
- (2013) Gaurav V. Harlalka et al. BRAIN
- Recent advances in physiological lipoprotein metabolism
- (2013) Indra Ramasamy CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Lifelong Expression of Apolipoprotein D in the Human Brainstem: Correlation with Reduced Age-Related Neurodegeneration
- (2013) Ana Navarro et al. PLoS One
- Importance of cholesterol in dopamine transporter function
- (2012) Kymry T. Jones et al. JOURNAL OF NEUROCHEMISTRY
- Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
- (2012) Gusheng Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
- (2011) Grit Taschenberger et al. ACTA NEUROPATHOLOGICA
- The fusogenic tilted peptide (67–78) of α-synuclein is a cholesterol binding domain
- (2011) Jacques Fantini et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells
- (2011) Kye-Young Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion
- (2011) Jacques Fantini et al. JOURNAL OF MOLECULAR BIOLOGY
- Unknown
- (2011) Noemi Fabelo et al. MOLECULAR MEDICINE
- Prospects of Statins in Parkinson Disease
- (2011) Avik Roy et al. NEUROSCIENTIST
- Apolipoproteins in the brain: implications for neurological and psychiatric disorders
- (2010) David A Elliott et al. Clinical Lipidology
- Membrane Cholesterol Modulates the Outward Facing Conformation of the Dopamine Transporter and Alters Cocaine Binding
- (2010) Weimin C. Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Central nervous system: cholesterol turnover, brain development and neurodegeneration
- (2009) John M. Dietschy BIOLOGICAL CHEMISTRY
- Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies
- (2009) Andrew O. Koob et al. EXPERIMENTAL NEUROLOGY
- Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor
- (2009) Lorraine N. Clark et al. PARKINSONISM & RELATED DISORDERS
- Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
- (2008) Timothy J Cunningham et al. Journal of Inflammation-London
- Role of ATP-binding cassette transporters in brain lipid transport and neurological disease
- (2008) Woojin Scott Kim et al. JOURNAL OF NEUROCHEMISTRY
- Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and α-synuclein in human neuroblastoma SH-SY5Y cells
- (2008) Jaya Prasanthi Rantham Prabhakara et al. JOURNAL OF NEUROCHEMISTRY
- Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
- (2008) Xuemei Huang et al. MOVEMENT DISORDERS
- Lipid rafts, cholesterol, and the brain
- (2008) Zeljka Korade et al. NEUROPHARMACOLOGY
- Early α-synuclein lipoxidation in neocortex in Lewy body diseases
- (2006) Esther Dalfó et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now